Capricor Therapeutics, Inc. (CAPR) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM), revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Revenue Growth (YoY) | -100.0% |
| EPS Growth (YoY) | 96.5% |
| FCF Growth (YoY) | 76.7% |
| Price / Book | 1.49 |
| Price / Sales | 21.17 |
| FCF Yield | -50.7% |
| Altman Z-Score | 3.11 (safe) |
| Sector P/E (Healthcare) | 21.7 |
CAPR overview · CAPR earnings · CAPR KPIs · CAPR investor relations · CAPR ownership · CAPR peers · CAPR filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.